Asset Details
Do you wish to reserve the book?
Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey
Do you wish to request the book?
Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey
2009
Overview
To assess the extent to which user fees for antiretroviral therapy (ART) represent a financial barrier to access to ART among HIV-positive patients in Yaoundé, Cameroon.
Sociodemographic, economic and clinical data were collected from a random sample of 707 HIV-positive patients followed up in six public hospitals of the capital city (Yaoundé) and its surroundings through face-to-face interviews carried out by trained interviewers independently from medical staff and medical questionnaires filled out by prescribing physicians. Logistic regression models were used to identify factors associated with self-reported financial difficulties in purchasing ART during the previous 3 months.
Of the 532 patients treated with ART at the time of the survey, 20% reported financial difficulty in purchasing their antiretroviral drugs during the previous 3 months. After adjustment for socioeconomic and clinical factors, reports of financial difficulties were significantly associated with lower adherence to ART (odds ratio, OR: 0.24; 95% confidence interval, CI: 0.15-0.40; P < 0.0001) and with lower CD4+ lymphocyte (CD4) counts after 6 months of treatment (OR: 2.14; 95% CI: 1.15-3.96 for CD4 counts < 200 cells/microl; P = 0.04).
Removing a financial barrier to treatment with ART by eliminating user fees at the point of care delivery, as recommended by WHO, could lead to increased adherence to ART and to improved clinical results. New health financing mechanisms based on the public resources of national governments and international donors are needed to attain universal access to drugs and treatment for HIV infection.
Publisher
Organisation mondiale de la santé,World Health Organization,The World Health Organization
Subject
/ Acquired immune deficiency syndrome
/ Adult
/ AIDS
/ Anti-Retroviral Agents - economics
/ Anti-Retroviral Agents - therapeutic use
/ Barriers
/ Biological and medical sciences
/ Cameroon
/ Capital
/ Donors
/ Drugs
/ Female
/ Health Services Accessibility - economics
/ HIV
/ HIV Infections - drug therapy
/ Human immunodeficiency virus
/ Humans
/ LDCs
/ Male
/ Patients
/ Public health. Hygiene-occupational medicine
/ Surveys
